In Conversation

Czech Republic Pharma Report April 2020
Latest Reports
Czech Republic Pharma Report April 2020
- 2020
Home to a USD 3.38 billion pharma market, one of Central and Eastern Europe’s most high-performing healthcare systems, and one of the region’s leading economies, the Czech Republic’s healthcare and life sciences market is fast closing the gap on its Western European equivalents. A traditionally tightly regulated domestic market is undergoing reform, and a more amenable administration is putting in place a system more conducive to the latest medical innovations. Notable progress has been made in the fields of preventative medicine, cutting-edge oncology treatments, and orphan drugs. However, the country’s reference pricing system, whereby reimbursement is set based on…
CEE Pharma Report
Latest Reports
CEE Pharma Report
- 2017
This special report offers companies, investors, policymakers, and stakeholders crucial insight into Central and Eastern Europe (CEE): a dynamic region, located strategically at the crossroads between Western Europe and the East, that has largely recovered from the global economic crisis of 2008 and is forging a formidable reputation for itself as a high-expertise, low-cost destination for the healthcare and life science industries. The report features in-depth and exclusive facts and figures on the region’s macroeconomy, healthcare systems, and pharmaceutical industries, as well as in-depth exclusive interviews with leading figures from public institutions and private companies, as well as comprehensive…
Czech Republic Pharma Report
Latest Reports
Czech Republic Pharma Report
- 2016
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of some of the largest pharmaceutical companies in the world. Located at the beating heart of Europe, boasting a highly-talented yet low-cost workforce, and with a rapidly evolving regulatory framework, the Czech Republic is fast establishing itself as a significant country globally for pharmaceuticals and healthcare. The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the…
Czech Republic Pharma Report
Latest Reports
Czech Republic Pharma Report
- 2012
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of some of the largest pharmaceutical companies in the world. Located at the beating heart of Europe, boasting a highly-talented yet low-cost workforce, and with a rapidly evolving regulatory framework, the Czech Republic is fast establishing itself as a significant country globally for pharmaceuticals and healthcare. The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the…
We use cookies to ensure that we give you the best experience on our site. For more info click here